共 10 条
[1]
Estes NAM, Garan H, Ruskin JN., Electrophysiologic properties of flecainide acetate, The American Journal of Cardiology, 53, (1984)
[2]
Holmes B, Heel RC., Flecainide: a preliminary review of its pharmacodynamic properties and therapeutic efficacy, Drugs, 29, pp. 1-33, (1985)
[3]
Package insert, (1990)
[4]
Miller LG, Jankovic J., Sulpiride‐induced tardive dystonia, Movement Disord, 5, pp. 83-84, (1990)
[5]
Miller LG, Jankovic J., Metoclopramide‐induced movement disorders: clinical findings with a review of the literature, Arch Intern Med, 149, pp. 2486-2492, (1989)
[6]
Gerlach J, Casey DE., Sulpiride in tardive dyskinesia, Acta Psychiatr Scand Suppl, 311, pp. 92-102, (1984)
[7]
Burke RE, Fahn S, Jankovic J, Et al., Tardive dystonia: lateonset and persistent dystonia caused by antipsychotic drugs, Neurology, 32, pp. 1335-1336, (1982)
[8]
Kang UJ, Burke RE, Fahn S., Natural history and treatment of tardive dystonia, Movement Disord, 1, pp. 193-208, (1986)
[9]
Wooten MP, Jankovic J., Bruxism in cranial‐cervical dystonia, Neurology, 40, (1990)
[10]
Jankovic J, Schwartz K, Donovan DT., Botulinum toxin treatment of cranial‐ cervical dystonia, spasmodic dystonia, other focal dystonias and hemifacial spasm, J Neurol Neurosurg Psychiatry, 53, pp. 633-639, (1990)